InvestorsHub Logo
icon url

Brinjal

08/23/20 3:54 PM

#319919 RE: olden_grumpini #319914

And I am sure you believe Earth is flat too!
icon url

frenchbroad

08/23/20 8:25 PM

#319959 RE: olden_grumpini #319914

*I agree that it’s ridiculous to ask for $35k if the drug you’re researching is the world-changing COVID therapeutic.* Sorry but I do not think you know what you talk about in the affaires of Ipix.
icon url

TheDane

08/23/20 9:41 PM

#319969 RE: olden_grumpini #319914

You’re forgetting that the RBL already said BrilAcidin is worth continued testing and, with IPIX, applied for a grant to that end. And, further, plans to publish the peer reviewed results from their work.

Go ipix!
icon url

Justfactsmam

08/24/20 5:44 AM

#319981 RE: olden_grumpini #319914

Hardly..."I agree that it’s ridiculous to ask for $35k if the drug you’re researching is the world-changing COVID therapeutic."

its a government/grant funded RBL...they work only on matters for which they are funded...as Leo stated $35k funding "costs" for additional research/testing outside RBL scope originally tasked for...was a bargain...the results of which imo will be invaluable and learned shortly

Grumpy...only thing ridiculous..and out of order are your conclusions/statements
icon url

roiresearch

08/24/20 6:17 AM

#319983 RE: olden_grumpini #319914

Brilacidin might be a line item with many other therapeutics however where are all the other GMU announcements that those other drugs have advanced to obtaining the ec50 values? Hmmmmmm. I cant find any other drug being researched in this fashion at gmu. Remember this was not an ipix pr but rather a GMU announcement longs came across.